Ras signaling in aging and metabolic regulation
Nutrition and Healthy Aging · 2017
DOI: 10.3233/nha-160021 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrition and Healthy Aging, 2017. Verfasst von Cathy Slack. Beteiligte Einrichtung: School of Life and Health Sciences, Aston University, Aston Triangle, Birmingham, UK. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Aberrant signal transduction downstream of the Ras GTPase has a well-established role in tumorigenesis. Mutations that result in hyperactivation of Ras are responsible for a third of all human cancers. Hence, small molecule inhibitors of the Ras signal transduction cascade have been under intense focus as potential cancer treatments. In both invertebrate and mammalian models, emerging evidence has also implicated components of the Ras signaling pathway in aging and metabolic regulation. Here, I review the current evidence for Ras signaling in these newly discovered roles highlighting the interactions between the Ras pathway and other longevity assurance mechanisms. Defining the role of Ras signaling in maintaining age-related health may have important implications for the development of interventions that could not only increase lifespan but also delay the onset and/or progression of age-related functional decline.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Life and Health Sciences, Aston University, Aston Triangle, Birmingham, UK.
Zitieren
APA
Slack, C. (2017). Ras signaling in aging and metabolic regulation. Nutrition and Healthy Aging. https://doi.org/10.3233/nha-160021
Vancouver
Slack C. Ras signaling in aging and metabolic regulation. Nutrition and Healthy Aging. 2017. doi:10.3233/nha-160021
BibTeX
@article{Slack2017,
author = {Slack, Cathy},
title = {Ras signaling in aging and metabolic regulation},
journal = {Nutrition and Healthy Aging},
year = {2017},
doi = {10.3233/nha-160021}
}
EUVIMED